Neuromuscular Reversal Flashcards
Neostigmine/Prostigmin, Bloxiverz
- MOA
- Side effects
MOA: acetylcholinesterase inhibitor - prevents breakdown of acetylcholine in neuromuscular junction
Side effects:
Neostigmine/Prostigmin, Bloxiverz
- Dose
- Onset
- Peak
- Duration
Dose:
- 0.03-0.07 mg/kg
- max 5mg (> 71 kg)
Onset: 1 minute
Peak: 9 minutes
Duration: 20-30 minutes
Neostigmine/Prostigmin, Bloxiverz
- Metabolism/Excretion
- Characteristics/observations
Metabolism/Excretion: 50% renal excretion
Characteristics/observations:
- antiemetic properties
- muscarinic effects must be blocked
Edrophonium/Enlon
- MOA
- Side effects
NOT AVAILABLE IN US MARKET
MOA: acetylcholinesterase inhibitor - prevents breakdown of acetylcholine in the synaptic cleft
Side effects:
NOT AVAILABLE IN US MARKET
Edrophonium/Enlon
- Dose
- Onset
- Peak
- Duration
NOT AVAILABLE IN US MARKET
Dose:
- 0.5-1 mg/kg (0.05-0.1 ml/kg) over 45-60 seconds
Onset: 3 minutes?
Peak: 1.2 minutes?
Duration: 70 minutes
NOT AVAILABLE IN US MARKET
Edrophonium/Enlon
- Metabolism/Excretion
- Characteristics/observations
NOT AVAILABLE IN US MARKET
Metabolism/Excretion:
- 75% renal excretion
- Elimination half-life = 33-110 minutes
Characteristics/observations:
- ?
NOT AVAILABLE IN US MARKET
Sugammadex/Bridion
- MOA
- Side effects
MOA: cyclodextrin which encapsulates NMBA, reducing amount present in neuromuscular junction
Side effects: will inhibit oral contraceptives for 7 days
Sugammadex/Bridion
- Dose
- Onset
- Peak
- Duration
Dose:
(dependent on TOF)
* TOF = 2: 2 mg/kg
* TOF = 0-2: 4 mg/kg
* More profound: 8-16 mg/kg
Onset: 1-5 minutes
Peak: ?
Duration: 120 minutes
Sugammadex/Bridion
- Metabolism/Excretion
- Characteristics/observations
Metabolism/Excretion: 75% renal excretion
Characteristics/observations:
- antiemetic properties
- muscarinic effects must be blocked